4th EUFEMED Conference

25-26 May 2023 - Berlin (Germany)

Mastering the New Time Pressure on Human Pharmacology

Focused strategies based on lessons learned in the pandemic

Thank you for your support and/or beeing part of the Exhibiton on-site!

status of 05/2023, in alphabetical order

Tabletop Presentation

Merck Sharp & Dohme, Rahway, NJ, USA – Grant of $ 5,000.00

Sponsorship 2.200 €

In accordance with the recommendations of the German Medical Association (Bundesärztekammer), the Association of Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) and the Voluntary Self-Regulation Body for the Pharmaceutical Industry (Freiwilliger Selbstkontrolle für die Arzneimittelindustrie e. V.), §20 para. 5. (FSA Codex Professionals, §20 para. 5), the contributions (amounts stated are net, before deduction of costs) of the industry partners are disclosed. The named companies participate in the 3rd EUFEMED in the exchange of services.

ARENSIA Exploratory Medicine GmbH · 1,000 €
Biokinetica S. A. ·  4,800 €
CRS Clinical Research Services Management GmbH · 1,500 €
CTC North GmbH & Co. KG · 1,000 €
Eurofins Optimed · 3,500 €
SGS Belgium NV · 1,500 €
SocraTec R&D GmbH · 1,500 €
Syndesi Therapeutics SA · 1,500 €

Amounts net, before deduction of costs.
Status: October 2022

Consent Management Platform von Real Cookie Banner